olivLaw · US equity research
Phaos Technology Holdings (Cayman) Limited POAS
Industrial Instruments For Measurement, Display, and Control · SIC 3823 · Vertical: Industrial Instruments For Measurement, Display, and Control (SIC 3823)
Phaos Technology Holdings (Cayman) Limited, listed on NYSE American, assembles and sells advanced optical microscopes through its Singapore subsidiary, alongside in-house software with AI components for quality control. The company is in a difficult period, with falling revenue and large net losses, as revenue in fiscal 2026 was S$132,077 compared with S$167,707 a year earlier.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, Phaos Technology Holdings (Cayman) Limited (POAS) stock was 0.85 USD (−21.83% on the day), with beta -0.16, 52-week range 0.85–99.00 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 27.8
- oversold (≤ 30)
- Bollinger (20, 2)
- 0.72 – 2.97
- in the lower half of the band · %B 0.06 · band width 121.8%
- SMA 50 / 200
- 2.23 / 17.98
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.38 / -0.27
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −61.1% | −1.1% | −60.1 pp | — |
| 3 months | −69.9% | −0.5% | −69.4 pp | — |
| 6 months | −97.6% | +4.4% | −102.0 pp | — |
| Year to date | −98.4% | +12.3% | −110.7 pp | — |
| 1 year | unavailable | +13.5% | unavailable | +27.8% |
| 3 years | unavailable | +76.4% | unavailable | +15.8% |
| 5 years | unavailable | +63.7% | unavailable | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | unavailable | 128.5 k | 103.7 k |
| Revenue YoY | unavailable | unavailable | −19.3% |
| Net income | unavailable | -3.9 m | -4.8 m |
| Net income YoY | unavailable | unavailable | unavailable |
| Diluted EPS | unavailable | -0.15 | -0.38 |
| Diluted EPS YoY | unavailable | unavailable | unavailable |
| net % | unavailable | -3,063.1% | -4,662.3% |
| Free cash flow | unavailable | -3.0 m | -8.6 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2026 · 30 Apr 2026
- Cash
- 598.4 k USD
- Financial debt
- 61.5 k USD
- Net debt
- -536.9 k USD
- Equity
- 4.2 m USD
- Total assets
- 5.2 m USD
- Debt / equity
- 0.01x
- Current ratio
- 5.11x
- ROE
- unavailable
- ROA
- -143.8%
- FCF margin
- -8,285.1%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2025 | 2026 | Source (latest year) |
|---|---|---|---|
| Revenue | 128.5 k | 103.7 k | SEC (XBRL)· 31 Aug 2026verified |
| Cost of revenue | 100.1 k | 90.1 k | SEC (XBRL)· 31 Aug 2026verified |
| Gross profit | 28.4 k ≈ | 13.6 k ≈ | SEC (XBRL)· 31 Aug 2026derived |
| Research & development | 107.0 k | — | SEC (XBRL)· 18 Sept 2025verified |
| Operating income | -4.0 m | -4.9 m | SEC (XBRL)· 31 Aug 2026verified |
| Interest expense | 6.5 k | 4.1 k | SEC (XBRL)· 31 Aug 2026verified |
| Pre-tax income | -3.9 m | -4.8 m | SEC (XBRL)· 31 Aug 2026verified |
| Net income | -3.9 m | -4.8 m | SEC (XBRL)· 31 Aug 2026verified |
| Diluted EPS | -0.15 | -0.38 | SEC (XBRL)· 31 Aug 2026verified |
| Weighted average diluted shares | 10.5 m | 12.6 m | SEC (XBRL)· 31 Aug 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Revenue − Cost of revenue.
Balance sheet · USD
| Line | 2025 | 2026 | Source (latest year) |
|---|---|---|---|
| Cash | 99.2 k | 598.4 k | SEC (XBRL)· 31 Aug 2026verified |
| Receivables | 29.4 k | 1.4 k | SEC (XBRL)· 31 Aug 2026verified |
| Inventories | 237.5 k | 426.9 k | SEC (XBRL)· 31 Aug 2026verified |
| Current assets | 1.2 m | 5.0 m | SEC (XBRL)· 31 Aug 2026verified |
| Property, plant & equipment, net | 219.5 k | 109.3 k | SEC (XBRL)· 31 Aug 2026verified |
| Total assets | 1.5 m | 5.2 m | SEC (XBRL)· 31 Aug 2026verified |
| Accounts payable | 72.0 k | 234.6 k | SEC (XBRL)· 31 Aug 2026verified |
| Short-term debt | 42.6 k | 45.8 k | SEC (XBRL)· 31 Aug 2026verified |
| Long-term debt | 60.0 k | 15.7 k | SEC (XBRL)· 31 Aug 2026verified |
| Current liabilities | 2.9 m | 978.8 k | SEC (XBRL)· 31 Aug 2026verified |
| Total liabilities | 3.0 m | 1.1 m | SEC (XBRL)· 31 Aug 2026verified |
| Equity | -1.5 m † | 4.2 m † | SEC (XBRL)· 31 Aug 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2025 | 2026 | Source (latest year) |
|---|---|---|---|
| Operating cash flow | -2.8 m | -8.6 m | SEC (XBRL)· 31 Aug 2026verified |
| Capex | 184.0 k | 31.2 k | SEC (XBRL)· 31 Aug 2026verified |
| Free cash flow | -3.0 m ≈ | -8.6 m ≈ | SEC (XBRL)· 31 Aug 2026derived |
| Investing cash flow | -255.0 k | 367.7 k | SEC (XBRL)· 31 Aug 2026verified |
| Financing cash flow | 1.4 m | 8.6 m | SEC (XBRL)· 31 Aug 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- indicators available: 4 of at least 6
- score weight coverage: 27.1% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: unavailable
Key indicators
Coverage and freshness
Score by group
27% · Insufficient data
Estimated value range
unavailable — no valuation method could be computed
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDAunavailable · input data missing
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
no valuation method could be computed
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 4 of at least 6; score weight coverage: 27.1% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | -386.0% | 0 (vs peers) | 38% |
| Net margin · Quality | -4,662.3% | 0 (vs peers) | 23% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -1,203.0x | 0 (on a fixed band) | 23% |
| Current ratio · Balance sheet | 5.1x | 100 (on a fixed band) | 15% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet40/100 · 2/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality0/100 · 2/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partialunavailable · 0/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Phaos Technology Holdings (Cayman) Limited (POAS). Latest full fiscal year: 2026; data up to 2026-04-30.
Figures computed from the financial statements: revenue 103.7 k USD in 2026; YoY growth -19.3%; net margin -4,662.3%; ROE -363.8%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (indicators available: 4 of at least 6; score weight coverage: 27.1% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Current ratio: 5.1x
What contradicts it
- ROIC: -386.0%
- Net margin: -4,662.3%
- Interest coverage: -1,203.0x
Not assessed (insufficient data or a ratio without meaning): FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Industrial Instruments For Measurement, Display, and Control (SIC 3823) · same industry (4-digit SIC) · compared with 15 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| DHRDanaher Corporation | 165.3 bn | 38.4 | 8.3% | 16.9% | +2.9% | +4% / +5% |
| AMEAMETEK, Inc. | 54.4 bn | 33.4 | 14.7% | 19.9% | +6.6% | +20% / +53% |
| ROPRoper Technologies, Inc. | 48.7 bn | 19.4 | 13.2% | 30.7% | +12.3% | +10% / −9% |
| KEYSKeysight Technologies, Inc. | 48.7 bn | 39.2 | 20.6% | 19.1% | +8.0% | +44% / +110% |
| FTVFortive Corporation | 20.3 bn | 32.5 | 10.5% | 14.8% | +1.9% | +28% / +31% |
| MKSIMks Inc. | 13.2 bn | 31.1 | 15.9% | 10.1% | +9.6% | +25% / +136% |
| CGNXCognex Corp | 8.9 bn | 51.3 | 11.1% | 16.1% | +8.7% | +39% / +41% |
| RALRalliant Corporation | 7.9 bn | — | -51.8% | -52.1% | −4.0% | +45% / unavailable |
| STSensata Technologies Holding PLC | 6.0 bn | 16.5 | 12.7% | 9.5% | −5.8% | +28% / +26% |
| MLABMesa Laboratories Inc | 706.1 m | 148.1 | 2.7% | 1.9% | +3.4% | +57% / +48% |
| SENSSenseonics Holdings, Inc. | 476.9 m | — | -118.2% | -225.3% | +56.9% | +46% / −24% |
| HURCHurco Companies, Inc. | 137.6 m | — | -3.3% | -3.6% | −4.3% | +31% / +1% |
| SYPRSypris Solutions, Inc. | 29.2 m | — | -69.9% | -9.2% | −14.5% | −42% / −33% |
| CLIRClearsign Technologies Corporation | 16.5 m | — | -51.7% | -96.1% | +45.6% | −67% / −80% |
| FCUVFocus Universal Inc. | 2.2 m | — | -106.0% | -637.2% | −35.9% | −98% / −99% |
| POASPhaos Technology Holdings (Cayman) Limited | — | — | -363.8% | -4,662.3% | −19.3% | unavailable / unavailable |
1- and 3-year price returns: for POAS from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Scenarios are not available. input data missing
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 31 Aug 2026; since then the company filed 6-K (27 Oct 2026), 6-K (19 Oct 2026), 6-K (02 Oct 2026), 6-K (30 Sept 2026), 6-K (18 Sept 2026), 6-K (04 Sept 2026).
In brief
Phaos Technology Holdings (Cayman) Limited, listed on NYSE American, assembles and sells advanced optical microscopes through its Singapore subsidiary, alongside in-house software with AI components for quality control. The company is in a difficult period, with falling revenue and large net losses, as revenue in fiscal 2026 was S$132,077 compared with S$167,707 a year earlier.
SWOT
Strengths
- The patented microsphere technology allows imaging below the traditional optical limit within a practical working distance, which sets the products apart 1.
- In-house proprietary software complements the hardware and enables integration, automation and AI-based inspection 1.
- Operating costs have been reduced significantly through workforce cuts and other management measures 1.
Weaknesses
Opportunities
- Expansion into Malaysia and other Southeast Asian markets could reduce dependence on Singapore and on large customers 1.
- A larger share of maintenance services could bring steadier, more recurring revenue 1.
- Adoption of AI quality-control solutions in electronics and precision industries could widen the customer base 1.
Risks
- Customer concentrationhigh
The largest customer's share of revenue has risen sharply, and losing it could seriously affect sales 1.
- Persistent net losseshigh
Net losses and the accumulated deficit grew in fiscal 2026, and continuing operations depend on revenue recovering 1.
- Management and audit changesmedium
Executive departures and the auditor change in March 2026 could create uncertainty about internal controls and continuity 1.
- Listing and share structuremedium
The proposed share consolidation aims to keep the NYSE American listing, but it does not guarantee a sustained rise in the share price 1.
- Costs and inflationmedium
Higher material, energy and transport costs could reduce margins if they cannot be passed on to customers 1.
Investment thesis
What would need to be true (bull case)
- If the microsphere technology proves robust in the market, the company could hold a rare niche with an edge over traditional optical microscopes 1.
- Cost reduction and a restructured direct sales effort could lead to a more efficient business if revenue stabilizes 1.
- Growth in AI software and maintenance services could bring more recurring revenue that is harder to replace 1.
What would break the thesis
- If customer orders remain delayed, revenue could keep falling and losses could deepen 1.
- Dependence on one major customer and a few large ones leaves the company exposed to decisions by a small number of buyers 1.
- Leadership changes, a new auditor and an accumulated deficit could make investor confidence and access to financing harder to secure 1.
What to watch
- Trend in revenue from microscopes and partsnext 10-K
- Outcome of the extraordinary meeting on share consolidation and the Class B share issuance2026
- Operating results of the Malaysia expansionQ1 2027
- Share of revenue from the largest customer and the five largest customersnext 10-K
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 31 Aug 2026; since then the company filed 6-K (27 Oct 2026), 6-K (19 Oct 2026), 6-K (02 Oct 2026), 6-K (30 Sept 2026), 6-K (18 Sept 2026), 6-K (04 Sept 2026).
The business
The company is an investment holding company incorporated in the Cayman Islands, operating through PTPL, its Singapore subsidiary established in February 2017. Products include super-resolution microscopes, specialized microscopes for various industries and 3-D real-time magnifiers, all based on a patented microsphere technology that allows imaging below the approximately 200 nm optical limit without vacuum or complex sample preparation 1. In-house software includes AI components using computer vision for inspection and QA/QC, deployed on customized machines with data stored locally at the customer 1.
Microscopes and parts remain the dominant revenue source, at 91.8% of revenue in fiscal 2026 1. Sales run through distributors and direct customer channels, mainly in Singapore and Indonesia, with expansion into Southeast and South Asia 1. The company cut its workforce from 25 to 10 in June 2025 and reduced monthly operating expenses below S$200,000 1.
Leadership changes in December 2025, the replacement of the auditor in March 2026 and a Form F-1 filed for a public offering of Class A shares describe a company in reorganization 1. An extraordinary meeting, reconvened for August 31, 2026, considered increasing authorized share capital, a share consolidation and an issuance of Class B shares to the chief executive as compensation for the IPO 1.
Segments
Market context
The company serves manufacturing, research and development, biomedical, semiconductor, PCB, electronics and precision engineering customers, with Singapore at 86.0% of group revenue in fiscal 2026 1. Malaysia is the main near-term expansion market, and the strategy includes reducing reliance on large customers, a relevant factor since the largest customer represented 38% of revenue 1.
Management attributes the revenue decline to delayed customer orders, and regional expansion depends on converting direct relationships into repeat orders 1. Presence in these segments could grow if direct relationships with end customers strengthen 1.
Trends
- Delayed customer ordersmixed
The fiscal 2026 revenue decline was attributed to delayed orders, while customer concentration rose sharply 1. If these orders resume, revenue could recover; otherwise pressure on sales may continue.
- Shift to direct sales channelsmixed
The strategy of selling directly to end customers aims for a broader base and less reliance on distributors 1. The company says it is uncertain whether margins may fall as a result, given competition and macroeconomic factors 1.
- Inflationary cost pressureheadwind
Inflation can raise the prices of materials and components, and energy and transport costs can affect production 1. The company could face higher procurement costs if these pressures persist.
- Focus on software and AItailwind
Development of AI components for inspection and QA/QC, and maintenance contracts, opens the possibility of recurring revenue if these solutions are widely adopted 1.
Competitive position
The source does not explicitly name the company's competitors. The company only notes that pricing and margins are influenced by competitors and innovation in the optical industry, without naming them 1.
The microsphere technology is presented as an alternative to electron microscopy, which requires vacuum and complex sample preparation, and to conventional diffraction-limited optical microscopy 1. The stated advantage is a practical working distance under ordinary laboratory conditions 1.
- Conventional optical microscopes
Makers of traditional optical microscopes limited by diffraction, which do not go below the roughly 200 nm limit described in the source 1.
- Electron microscopy
Alternative high-resolution technology that requires vacuum and extended sample preparation, as described by the company 1.
- AI inspection solution providers
Companies offering computer vision for quality control, indirect competitors to the company's software components 1.
- Regional distributors
Distribution partners in Singapore, Indonesia and Southeast Asia, whose share of sales the company is trying to reduce 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report (foreign issuer)27 Oct 2026
- Current report (foreign issuer)19 Oct 2026
- Current report (foreign issuer)02 Oct 2026
- Current report (foreign issuer)30 Sept 2026
- Current report (foreign issuer)18 Sept 2026
- Current report (foreign issuer)04 Sept 2026
- Annual report (foreign issuer)31 Aug 2026
- Current report (foreign issuer)13 Aug 2026
- Current report (foreign issuer)12 Aug 2026
- Current report (foreign issuer)27 Jul 2026
Sources
- [1] Form 20-F, fiscal year ended 2026-04-30 · SEC / Phaos Technology Holdings (Cayman) Limited · 31 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.